Virtus ETF Advisers’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-51,919
| Closed | -$266K | – | 415 |
|
|
2021
Q3 | $266K | Sell |
51,919
-4,755
| -8% | -$28.9K | 0.12% | 212 |
|
|
2021
Q2 | $471K | Buy |
56,674
+8,726
| +18% | +$73.6K | 0.19% | 169 |
|
|
2021
Q1 | $418K | Buy |
47,948
+1,310
| +3% | +$13.6K | 0.18% | 175 |
|
|
2020
Q4 | $506K | Buy |
46,638
+12,952
| +38% | +$160K | 0.21% | 139 |
|
|
2020
Q3 | $402K | Buy |
33,686
+2,837
| +9% | +$38K | 0.21% | 169 |
|
|
2020
Q2 | $495K | Buy |
30,849
+10,543
| +52% | +$184K | 0.23% | 149 |
|
|
2020
Q1 | $315K | Sell |
20,306
-2,966
| -13% | -$63.7K | 0.13% | 221 |
|
|
2019
Q4 | $572K | Buy |
23,272
+1,552
| +7% | +$23K | 0.09% | 195 |
|
|
2019
Q3 | $224K | Sell |
21,720
-1,210
| -5% | -$15.3K | 0.05% | 229 |
|
|
2019
Q2 | $288K | Sell |
22,930
-22,532
| -50% | -$290K | 0.06% | 235 |
|
|
2019
Q1 | $563K | Sell |
45,462
-5,376
| -11% | -$60.1K | 1.2% | 26 |
|
|
2018
Q4 | $313K | Buy |
50,838
+20,983
| +70% | +$160K | 0.05% | 97 |
|
|
2018
Q3 | $316K | Sell |
29,855
-21,348
| -42% | -$244K | 0.04% | 184 |
|
|
2018
Q2 | $694K | Sell |
51,203
-8,127
| -14% | -$126K | 0.61% | 103 |
|
|
2018
Q1 | $1.05M | Buy |
59,330
+31,789
| +115% | +$537K | 0.91% | 35 |
|
|
2017
Q4 | $346K | Buy |
27,541
+832
| +3% | +$12.1K | 0.43% | 98 |
|
|
2017
Q3 | $509K | Buy |
26,709
+2,443
| +10% | +$37.3K | 0.07% | 88 |
|
|
2017
Q2 | $366K | Sell |
24,266
-1,062
| -4% | -$16.1K | 0.05% | 82 |
|
|
2017
Q1 | $434K | Buy |
25,328
+2,428
| +11% | +$32.3K | 0.08% | 110 |
|
|
2016
Q4 | $277K | Buy |
22,900
+1,150
| +5% | +$12K | 0.08% | 117 |
|
|
2016
Q3 | $214K | Hold |
21,750
| – | – | 0.1% | 136 |
|
|
2016
Q2 | $223K | Buy |
21,750
+5,350
| +33% | +$59.7K | 0.17% | 120 |
|
|
2016
Q1 | $199K | Buy |
+16,400
| New | +$166K | 0.27% | 83 |
|
Other funds holding EPZM
RM
PAI
RSCM
MB
PIM